Performance and Use of HSV Type-specific Serology Test Kits

Herpes

Volumn 9, Issue 2, 2002, Pages 38-45

  Ashley, Rhoda L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antibody testing; Genital herpes; Herpes simplex virus (HSV); Serology

Indexed keywords

THROMBOSPONDIN; VIRUS ANTIBODY; HERPES SIMPLEX VACCINE;

AUTOANALYSIS; COST; DIAGNOSTIC KIT; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENITAL HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; SYMPTOMATOLOGY; ANALYTICAL EQUIPMENT; BLOOD; FOOD AND DRUG ADMINISTRATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEROLOGY; STANDARD; UNITED STATES; VIROLOGY; WESTERN BLOTTING;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

ANTIBODIES, VIRAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPES GENITALIS; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0036631862     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Tunback P, Liljeqvist JA, Lowhagen GB, Bergstrom T. Glycoprotein G of herpes simplex virus type 1: identification of type-specific epitopes by human antibodies. J Gen Virol 2000;81:1033-1040.
2. Liljeqvist JA, Trybala E, Svennerholm B, Jeansson S, Sjogren-Jansson E, Bergstrom T. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen Virol 1998;79:1215-1224.
3. Marsden HS, MacAulay K, Murray J, Smith IW. Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis. J Med Virol 1998;56:79-84.
4. Ashley RL. Type-specific antibodies to HSV-1 and 2: review of methodology. Herpes 1998;5:33-38.
5. Mertz GJ, Coombs RW, Ashley R, Jourdan J, Remington M, Winter C et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 1988;157:1169-1177.
6. Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999;12:1-8.
7. Koutsky LA, Ashley RL, Holmes KK, Stevens CE, Critchlow CW, Kiviat NB et al. The frequency of unrecognized type 2 herpes simplex virus infection among women: implications for the control of genital herpes. Sex Transm Dis 1990;17:90-94.
8. Koutsky LA, Stevens CE, Holmes KK, Ashley RL, Kiviat NB, Critchlow CW et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992;326:1533-1539.
9. Nahmias A, Lee F, Beckman-Nahmias S. Seroepidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990;69:19-36.
10. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-1111.
11. Patrick DM, Dawar M, Cook DA, Krajden M, Ng HC, Rekart ML. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women. Sex Transm Dis 2001;28:424-428.
12. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (Immunoblot) and G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988;26:662-667.
13. Ashley RL. Current concepts of laboratory diagnosis of herpes simplex infection. In: Clinical Management of Herpes Viruses (Sacks SL, Straus SE, Whitley RJ, Griffiths PD, eds). Washington DC, IOS Press, 1995; pp137-171.
14. Lee F, Coleman R, Pereira L, Bailey P, Tatsuno M, Nahmias A. Detection of herpes simplex virus type 2 specific antibody with glycoprotein G. J Clin Microbiol 1985;22:641-644.
15. Lee FK, Pereira L, Griffin C, Reid E, Nahmias A. A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J Virol Methods 1986;14:111-118.
16. Gopal R, Gibbs T, Slomka MJ, Whitworth J, Carpenter LM, Vyse A et al. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa. J Virol Methods 2000;87:71-80.
17. Ho DWT, Field PR, Sjogren-Jansson E, Jeansson S, Cunningham AL. Indirect ELISA for the detection of IgG and IgM antibodies and glycoprotein G (gG2). J Virol Methods 1992;36:249-264.
18. Ho DWT, Field PR, Irwing WL, Packham DR, Cunningham AL. Detection of immunoglobulin M antibodies to glycoprotein G-2 by Western blot (immunodot) for diagnosis of initial herpes simplex genital infections. J Clin Microbiol 1993;31:3157-3164.
19. Svennerholm B, Olofsson S, Jeansson S, Vahlne A, Lycke E. Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbial 1984;19:235-239.
20. Ashley RL, Wu L, Pickering JW, Tu M-C, Schnorenberg L. Premarket evaluation of a commercial glycoprotein-G based enzyme immunoassay for herpes simplex virus type-specific antibodies. J Clin Microbiol 1998;36:294-295.
21. Whittington WL, Celum CL, Cent A, Ashley RL. Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics. Sex Transm Dis 2001;28:99-104.
22. Ashley RL. Sorting out the new HSV type specific antibody tests. Sex Transm Infect 2001;77:232-237.
23. Eagleton M, Smart D, Warren T, McCormack W, Stern J, Goodgame J et al. A new accurate point of care test kit, POCkit™ for the diagnosis of HSV-2 infection (abstract). 13th Meeting of the International Society for Sexually Transmitted Disease Research, 1999.
24. Hosein H, Weiner R, Jackson B, Dhillon C, Black L. Field evaluation of the QuickVue™ herpes simplex virus antibody test. Annual Meeting of the Infectious Disease Society of America, 2001;p197.
25. Groen J, Van Dijk G, Niesters H, Van Der Meijden W, Osterhaus A. Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2-specific antibodies in serum. J Clin Microbiol 1998;36:845-847.
26. Garcia-Corbeira P, Dal-Re R, Aguilar L, Granizo JJ, Garcia-de-Lomas J. Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population? J Med Virol 1999;59:194-197.
27. Varela JA, Garcia-Corbeira P, Aguanell V, Boceta R, Ballesteros J, Aguilar L et al. Herpes simplex virus type 2 seroepidemiology in Spain. Sex Transm Dis 2001;28:47-50.
28. Woolley PD, Chandiok S, Pumphrey J, Sharratt S, Shanley L, Bennett S. Serological prevalence of herpes simplex virus type 2 amongst GUM clinic attenders in a district general hospital setting. Int J STD AIDS 2000;11:379-382.
29. Gibney L, Macaluso M, Kirk K, Hassan MS,Schwebke J, Vermund SH et al. Prevalence of infectious diseases in Bangladeshi women living adjacent to a truck stand: HSV/Sex Transm Dis/hepatitis/genital tract infections. Sex Transm Infect 2001;77:344-350.
30. Eis-Hubinger AM, Daumer M, Matz B, Schneweis KE. Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera. J Clin Microbiol 1999;37:1242-1246.
31. Ashley R, Cent A, Maggs V, Corey L. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus type 1 and 2. Ann Intern Med 1991;115:520-526.
32. Martins TB, Woolstenhulme RD, Jaskowski TD, Hill HR, Litwin CM. Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus. Am J Clin Pathol 2001;115:272-277.
33. Ashley R, Corey L. Herpes simplex viruses and B virus. In: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, 6th edn (Schmidt NJ, Emmons R, eds). Washington, DC: American Public Health Association, 1989;pp265-317.
34. Saville M, Brown D, Burgess C, Perry K, Barton S, Cowan F et al. An evaluation of near patient tests for detecting herpes simplex virus type-2 antibody. Sex Transm Infect 2000;76:381-382.
35. Diagnology (Belfast, Northern Ireland, UK). POCkit™ HSV-2 technical support. Available at: www.pockitpro.com (accessed 30 April 2002).
36. Koertge TE, Butler JE. The relationship between the binding of primary antibody to solid-phase antigens in microtiter plates and its detection by the ELISA. J Immun Methods 1985;83:283-299.
37. Wald A, Ashley R. Serologic testing for HSV-1 and HSV-2 infection. Clin Infect Dis 2002 (in press)
38. Lafferty WE, Krofft S, Remington M, Giddings R, Winter C, Cent A et al. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high prevalence population. J Clin Microbiol 1987;25:323-326.
39. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124:8-15.
40. Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having 'asymptomatic' HSV-2 infection. Ann Intern Med 1989;110:882-887.
41. Frenkel LM, Garratty EM, Shen JP, Wheeler N, Clark O, Bryson YJ. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 1993;118:414-418.
42. Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic HSV-2 seropositive persons. N Engl J Med 2000;342:844-850.
43. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection: influence of anatomic site and viral type. N Engl J Med 1987;316:1444-1449.
44. Sucato G, Wald A, Wakabayashi E, Vieira J, Corey L. Evidence of latency and reactivation of both herpes simplex virus (HSV-1) and HSV-2 in the genital region. J Infect Dis 1998;177:1069-1072.
45. Samarai A, Shareef A, Kinghorn G, Potter C. Sequential genital infections with herpes simplex virus types 1 and 2. Genitourin Med 1989;65:39-41.
46. Sluman VJ, Ilstrup DM. Predictive value of viral diagnostic tests. In: Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections, 7th edn (Lennette EH, Lennette DA, Lennette ET, eds). Washington, DC: American Public Health Association, 1995; pp155-159.
47. Ashley RL, Wald A, Eagleton M. Pre-market evaluation of the POCkit™ HSV-2 type specific serologic test in culture-documented cases of genital herpes simplex virus type 2. Sex Transm Dis 2000;27:266-269.
48. Wald A, Langenberg A, Link K, Izu AE, Ashley R, Warren T et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-3106.
49. Brown ZA, Selke SA, Zeh J, Kopelman J, Maslow A, Ashley R et al. Acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-515.
50. Kulhanjian JA, Soroush V, Au DS, Bronzan RN, Yasukawa LL, Weylman LE et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992;326:916-920.
51. Brown ZA, Benedetti J, Ashley R, Birchett S, Selke S, Berry S et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247-1252.
52. Prince HE, Ernst CE, Hogrefe WR. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. J Clin Lab Anal 2000;14:13-16.
53. Ribes JA, Hayes M, Smith A, Winters JL, Baker DJ. Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL Diagnostics. J Clin Microbial 2001;39:3740-3742.
54. Eberhart-Phillips JE, Dickson NP, Paul C, Herbison GP, Taylor J, Cunningham AL. Rising incidence and prevalence of herpes simplex type 2 infection in a cohort of 26 year old New Zealanders. Sex Transm Infect 2001;77:353-357.
55. Tayal SC, Pattman RS. High prevalence of herpes simplex virus type 1 in female anogenital herpes simplex in Newcastle upon Tyne 1983-92. Int J STD AIDS 1994;5:359-361.
56. Christie SN, McCaughey C, McBride M, Coyle PV. Herpes simplex type 1 and genital herpes in Northern Ireland. Int J STD AIDS 1997;8:68-69.
57. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000;181:1454-1457.
58. Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000;76:183-187.
59. Lowhagen G-B, Tunback P, Andersson K, Bergstrom T, Johannisson G. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect 2000;76:179-182.
60. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infection: clinical manifestations, course and complications. Ann Intern Med 1983;98:958-972.
61. Corey L, Wald A, Genital herpes. In: Sexually Transmitted Diseases, 3rd edn (Holmes KK, Sparling PF, Mardh PA, Piot P, Sparling P, Stamm W et al., eds). New York: McGraw-Hill, 1999; pp285-312.
62. Langenberg A, Corey L, Ashley R, Leong W, Straus S. A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J Med 1999;341:1432-1438.
63. Brown ZA. HSV-2 specific serology should be offered routinely to antenatal patients. Rev Med Virol 2000;10:141-144.
64. Ashley RL, Eagleton M, Pfeiffer N. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol 1999;37:1632-1633.
65. Ashley RL, Benedetti J, Corey L. Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes. J Med Viral 1985;17:153-166.
66. Ashley R, Koelle DM. Immune responses to genital herpes infection. In: Advances in Host Defense Mechanisms Vol 8 Sexually Transmitted Diseases (Quinn TC, ed). New York: Raven Press, 1992;pp201-238.
67. Schmid DS, Brown DR, Nisenbaum R, Burke RL, Alexander D-A, Ashley R et al. Limits in the reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol 1999;37:376-379.
68. Ashley RL, Pickering J, Pfeiffer N, Wei S, Wu L. Early diagnosis of first episode genital herpes simplex virus (HSV) infection by enzyme immunoassay (EIA) for type-specific IgM antibodies. 98th Annual Meeting of the American Society for Microbiology, 1998.
69. Corey L, Langenberg AGM, Ashley R, Sekulovich RE, Izu AE, Douglas JM, Jr et al., for the Chiron HSV Vaccine Study Group. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. JAMA 1999;282:331-340.
70. Leach C, Ashley R, Baillergeon J, Jenson H. Evaluation of glycoprotein-G based enzyme immunoassay (gG-ELISA) for type-specific antibodies to herpes simplex virus type 1 and type 2 in HIV-positive and HIV-negative children and adolescents. In: Proceedings from the Annual Meeting of the Infectious Disease Society of America, 2000;p258.
71. Leach CT, Ashley RL, Baillargeon J, Jenson HB. Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents. J Clin Microbiol 2002 (in press).
72. Corey L, Handsfield HH. Genital herpes and public health: addressing a global problem. JAMA 2000;283:791-794.
73. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases - United States recommendations of the advisory committee for HIV and STD prevention. MMWR 1998;47:1-24.
74. Fairley I, Monteiro EF. Patient attitudes to type specific serologic tests in the diagnosis of genital herpes. Genitourin Med 1997;73:259-262.